Niven R. Narain is the Co-Founder, President, and CEO of Berg, a Boston-based biopharma taking a “back to biology” approach to tackling some of society’s most difficult diseases like cancer, diabetes, and parkinson’s disease. He is a recognized expert in use of AI in medicine and cancer systems medicine. His technology is subject of numerous collaborations with leading institutions such as Harvard Medical School, Stanford, Cornell, and MD Anderson among others in addition to key government relationships with the DoD, NIH, and Genomics England. He is a frequent speaker at leading scientific, medical, and healthcare conferences such as WIRED, the Economist, Bloomberg, and the Aspen Ideas Festival. Niven’s work has been featured in international media outlets such as Forbes, Fortune, BBC, Fox Business, Bloomberg, and the Telegraph. His passion is putting the power back into the patient and physician to realize the power of precision medicine.